The national launch meeting for the Phase III clinical study of Guizhou BaiLing TangNing TongLuo tablets was successfully held
Zhitong
On January 18th, the "National Launch Conference for the Clinical Research of Guizhou Bailing's Tangning Tongluo Tablets for the Treatment of Non-Proliferative Diabetic Retinopathy" was successfully held in the Guangdong-Hong Kong-Macao Greater Bay Area, marking a key development stage for the project
